Delong Liu is an Oncology physician affiliated with Westchester Medical Center. OpenAlex indexes 313 publications with 13,118 citations (h-index 61).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
19 Bradhurst Ave
Suite 2100
Hawthorne, NY 105322140
Telephone
914-493-8375Registry record last updated 16 Jul 2019.
Industry payments
24 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- BeOne Medicines USA, Inc.Program year202514 payments$28,377openpaymentsdata.cms.gov ↗
- Rigel Pharmaceuticals, Inc.Program year202513 payments$23,021openpaymentsdata.cms.gov ↗
- Geron CorporationProgram year20257 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
46.5%Kinase inhibitor19.2%Jakafi43%Brukinsa27%Imatinib Mesylate16%Tasigna15%Part D<11 patientsThalidomide Analog12.9%Revlimid64%Pomalyst36%Part D<11 patients+ 3 more classes in this area
Dermatology
18.3%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor18.3%Acyclovir100%Part D≥18 patientsAnti-infectives
12.2%Azole Antifungal12.2%Fluconazole100%Part D≥12 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Combination strategies to maximize the benefits of cancer immunotherapy
Journal of Hematology & Oncology
2021 - Next-generation immuno-oncology agents: current momentum shifts in cancer immunotherapy
Journal of Hematology & Oncology
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Stephan Mayer, MD
Westchester Medical Center
William Frishman, MD
Westchester Medical Center
Srihari Naidu, MD
Westchester Medical Center
Steven Lansman, MD
Westchester Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”